FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama
An FDA advisory committee has unanimously recommended the approval of Moderna's mRNA influenza vaccine for older adults.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
A federal vaccine panel voted unanimously to recommend the authorization of Moderna’s mRNA-based flu vaccine. This decision marks the first time such an advisory committee has recommended a vaccine since 2023. The shot is intended for use in older adult populations.
Coverage from CIDRAP, NPR, Stat News, FirstWord Pharma, WRAL, NBC News, and Ars Technica emphasizes the unanimous nature of the vote. Reports also note that the approval process followed a period of agency drama and controversy surrounding the vaccine. Next steps involve the formal FDA regulatory process following this panel endorsement.
Coverage does not yet specify a final timeline for the vaccine's availability.
Synthesized by PULSE from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 89d ago.
Quick answers
Who is the vaccine for?
According to NBC News, the vaccine is intended for older adults.
What technology does the vaccine use?
The vaccine utilizes mRNA technology, described by reporting as first-of-its-kind for a flu shot.
Was the committee vote divided?
No, multiple outlets including Ars Technica and NPR report the vote was unanimous.
Coverage (7)
- Moderna’s mRNA flu vaccine gets thumbs up from federal vaccine panel CIDRAP · 91d ago
- Key FDA committee unanimously recommends its first vaccine since 2023 NPR · 91d ago
- FDA advisory panel endorses Moderna mRNA flu vaccine that was subject of controversy statnews.com · 91d ago
- FDA panel strongly backs Moderna's mRNA flu vaccine FirstWord Pharma · 91d ago
- FDA panel considers a first-of-its-kind flu vaccine using mRNA technology WRAL · 91d ago
- FDA panel recommends Moderna’s mRNA flu shot for older adults NBC News · 91d ago
- FDA advisors unanimously vote to approve Moderna’s mRNA after agency drama Ars Technica · 91d ago
Topics
Related trends
Inside RFK’s Jr.’s ‘Backdoor’ Approach to Stop Vaccines
Coverage examines Robert F. Kennedy Jr.'s strategy regarding vaccine safety and measles outbreaks.
Clinicians Should Be on Alert for Measles in Adults, Say Experts
8 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
FDA Announces Hand Soap Recall in 15 States—Thousands of Bottles May Contain Bacteria
An FDA-announced hand soap recall spans multiple states due to potential antibiotic-resistant bacterial contamination.
Trust in measles vaccines falls in US, Reuters Ipsos poll finds
Public trust in measles vaccines declines across the United States as national cases reach a 35-year high.
Psychedelics Stock, Up 190% This Year, Flies High Again
11 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Experts urge FDA to set clear safety and access standards for psychedelic drugs
9 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.